Friday, July 31, 2026

Kim Jong Un Era: How North Korea’s New Political Stance Signals a Shift in Military and Economic Priorities

North Korea's 9th Workers' Party Congress marks a shift from military-first to a dual focus on defense and economy under Kim Jong Un.

10 Signs You Might Have Endometriosis: Understanding Symptoms and Seeking Early Diagnosis

Endometriosis affects many women, causing severe pain and potential infertility. Early diagnosis and treatment are crucial for managing symptoms.

North Korea Justifies and Formalizes 4th Generational Succession System

North Korea is normalizing a fourth hereditary succession with Kim Jong Un's daughter, Ju-ae, being groomed for leadership roles.

Tag: Medipost

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.